Elanco Expands-Renovates Elwood, Kansas, Operations
08/21/2024
The investment will include the renovation of the company’s existing facility which currently manufactures and ships its Canine Parvovirus Monoclonal Antibody and will be the flagship location for future monoclonal antibody manufacturing.
“Expanding the capabilities at our Elwood manufacturing site is a critical step toward executing the most exciting pipeline in Elanco’s 70-year history,” Elanco Manufacturing and Quality Executive Vice President Grace McArdle said. “In partnership with our Elanco research and development colleagues, this site plays a key role in delivering solutions that are transforming the way veterinarians and pet owners care for the world’s animals. We appreciate the commitment of the State of Kansas, Doniphan County, and the City of Elwood to help pets live longer, healthier, more active lives.”
Elanco Animal Health Incorporated is a pharmaceutical company which produces medicines and vaccinations for pets and livestock. The company was a subsidiary of Eli Lilly and Company, before being divested.
“Sitting in the heart of the Animal Health Corridor, Kansas is a powerhouse in this critical sector – attracting companies from across the nation and around the world,” Lieutenant Governor and Secretary of Commerce David Toland noted “Elanco is an excellent example of the top-notch employers the Kelly-Toland administration is committed to partnering with as we grow the state's economy.”
Project Announcements
ValorFlex Packaging Plans Bowling Green, Kentucky, Production Operations
06/30/2025
Neuro.io Plans Terrebonne Parish, Louisiana, Operations
06/30/2025
Germany-Based MTU Maintenance Expands Fort Worth, Texas, MRO Operations
06/30/2025
Cascade Die Casting Group Expands High Point, North Carolina, Manufacturing Operations
06/30/2025
BuildOps Plans Raleigh, North Carolina, Operations
06/30/2025
Point Blank Enterprises Plans Wakulla County, Florida, Operations
06/30/2025
Most Read
-
20th Annual Area Development Gold and Silver Shovel Awards
Q2 2025
-
First Person: Joe Capes, CEO, LiquidStack
Q2 2025
-
The Legal Limits of DEI in Incentives Agreements, Hiring, and Contracting
Q2 2025
-
From Silicon to Server: Mapping the Data Center Supply Chain
Q2 2025
-
39th Annual Corporate & 21st Annual Consultants Surveys: What Business Leaders and Consultants Are Saying About Site Selection
Q1 2025
-
Rethinking Life Sciences Site Selection in a Resilient and Dynamic Market
Q2 2025
-
Top States for Doing Business in 2024: A Continued Legacy of Excellence
Q3 2024